|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Income earned on investments held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Increase in prepaid expenses | |
| Increase in accounts payable | |
| Increase in accrued expenses | |
| Increase in deferred compensation – related parties | |
| Net cash used in operating activities | |
| Cash flows from investing activities | |
| Investment of cash into Trust Account | |
| Net cash used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from Sponsor Note | |
| Repayment of Sponsor Note | |
| Proceeds from sale of Units | |
| Proceeds from sale of Private Placement Units | |
| Payment of underwriting discounts and reimbursements | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash and cash equivalents – beginning of period | |
| Cash and cash equivalents – end of period | |
| Supplemental disclosure of noncash activities: | |
| Deferred underwriting costs payable | |
| Deferred offering costs included in accounts payable |
Loading...
